CST: 03/12/2016 21:52:10   

San Diego Chargers Safety Darrell Stuckey Rehabs With Alkame Water After Meniscus Knee Surgery

298 Days ago

LAS VEGAS, NV--(Marketwired - Feb 9, 2016) - Alkame Holdings, Inc. (OTC: ALKM), a publicly traded health and wellness technology holding company with a focus on patentable, innovative, and eco-friendly products, announced today that its wholly owned subsidiary, Alkame Water, Inc.'s The Ultimate Health and Wellness Water, a patented formula of premium oxygenated, alkaline, bottled water products enhanced with antioxidants and electrolytes, is playing an integral part of Darrell Stuckey's post Meniscus knee surgery rehab and recovery, and will be chronicling the recovery process.

Returning to the NFL after Meniscus surgery is no easy feat. Stuckey will be utilizing Alkame Water as a key and integral part of his recovery and post-op physical therapy. Alkame may help reduce swelling and flush toxins while aiding Darrell in getting the full range of motion, strengthening, and neuromuscular control. Meniscus damage is typically caused by a blow to the knee from the outside or a sudden stop and are common in football.

Eakle states, "Many athletes come back to their sport too soon, and may not have their full strength or balance regained. We are so glad that Darrell's emphasis is on the quality of his recovery, realizing that proper hydration with Alkame may assist in that recovery process."

Darrell stated, "The first few months are critical for me to reduce the swelling and pain, while flushing out those toxins. I know it will be extremely tough, and I plan to put in the long hours during the off season." Darrell added, "I will be journaling my updates and progress weekly for Alkame so they can keep both of our social media followers updated on my progress, as I know Alkame will play a key part in my rapid recovery and aid in my bouncing back faster."

Darrell Stuckey Jr.(II), is a San Diego Chargers Safety and Special Teams Captain, and has been for the last 4 years in a row. The Chargers nominated Darrell for the 2015 Walter Payton NFL Man of the Year Award, for his work in the community as well as his outstanding play on the field.

Robert Eakle states, "We are glad that we can play a part in Darrell's recovery. Drinking Alkame during his rehab will hopefully speed up his return to football with no pain, no swelling, and a full range of motion with good stability and strength equal to his other knee."

About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and wellness technology holding company, with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiaries market and distribute enhanced waters utilizing an exclusive patented formula and technology to create water with several unique properties, enabling an increase to available oxygen content, optimized pH levels, as well as the added benefits of electrolytes, and enhancement of antioxidant properties, equating into many potential health benefits, such as a reduced structure for permeability, improved metabolic efficiency, a boosted immune system, improved cardio respiratory function, and a decrease in lactic acid for faster muscle recovery. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications to utilize its Intellectual Property by placement into several emerging business sectors, such as the growing aqua-culture industry, consumer bottled water and RTD products, household pet products, horticulture and agriculture applications, as well as many other various water treatment solutions to both new and existing business platforms.

For more information, visit www.alkameholdingsinc.com

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

Alkame Holdings, Inc. Investor Relations
Investor Awareness, Inc.
Tony Schor
(888) 391-9990 (Toll-free) ext. 221
Website: www.alkameholdingsinc.com
Email: info@alkameholdingsinc.com